Compare $CLBT vs $RSKD | Chartloom

Compare

$CLBT vs $RSKD

Cellebrite DI Ltd · Riskified Ltd

CLBT

Cellebrite DI Ltd

RSKD

Riskified Ltd

Compare $CLBT vs $RSKD

Comparing Cellebrite DI Ltd and Riskified Ltd

CLBTCellebrite DI Ltd

RSKDRiskified Ltd

CLBTCellebrite DI Ltd

Market cap

$2.81B

P/E (TTM)

48.87x

Forward P/E (NTM)

18.00x

Forward P/S (NTM)

4.59x

Rev growth (TTM)

17.8%

YTD performance

-36.9%

52W performance

-40.7%

FCF yield

4.6%

RSKDRiskified Ltd

Market cap

$1.14B

P/E (TTM)

—

Forward P/E (NTM)

26.34x

Forward P/S (NTM)

2.61x

Rev growth (TTM)

9.6%

YTD performance

77.3%

52W performance

83.0%

FCF yield

4.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLBT

RSKD

Detailed metrics comparison

CLBT

Cellebrite DI Ltd

RSKD

Riskified Ltd

Market Cap

CLBT$2.81B

RSKD$1.14B

Enterprise Value

CLBT$2.67B

RSKD$1.04B

Price

CLBT$11.26

RSKD$8.53

P/E Ratio

CLBT48.87x

RSKDN/A

P/S Ratio

CLBT5.46x

RSKD3.10x

EV/Sales

CLBT5.19x

RSKD2.81x

EV/EBITDA

CLBT28.85x

RSKD0.00x

P/B Ratio

CLBT5.17x

RSKD4.96x

P/FCF Ratio

CLBT21.85x

RSKD24.79x

EV/FCF

CLBT20.75x

RSKD22.50x

PEG Ratio

CLBT2.85x

RSKDN/A

Forward P/E (NTM)

CLBT18.00x

RSKD26.34x

Forward P/S (NTM)

CLBT4.59x

RSKD2.61x

Revenue (TTM)

CLBT$514M

RSKD$368M

Revenue Growth (YoY)

CLBT17.8%

RSKD9.6%

Forward Rev Growth

CLBT15.1%

RSKD10.9%

Gross Margin (TTM)

CLBT83.0%

RSKD51.3%

Operating Margin (TTM)

CLBT10.9%

RSKD0.0%

EBITDA Margin (TTM)

CLBT15.2%

RSKD-3.6%

Net Margin (TTM)

CLBT11.3%

RSKD-4.2%

FCF Margin (TTM)

CLBT25.0%

RSKD12.5%

Net Income (TTM)

CLBT$58M

RSKD$-16M

FCF (TTM)

CLBT$129M

RSKD$46M

EPS (TTM)

CLBT$0.23

RSKD-$0.11

ROE (TTM)

CLBT11.9%

RSKD-570.0%

ROA (TTM)

CLBT6.3%

RSKD-405.0%

ROIC (TTM)

CLBT11.9%

RSKD-570.0%

Cash

CLBT$141M

RSKD$105M

Debt

CLBT$0

RSKD$0

Net Cash/Debt

CLBT$141M

RSKD$105M

Current Ratio (TTM)

CLBT1.62x

RSKD3.62x

Quick Ratio (TTM)

CLBT1.54x

RSKD3.45x

Debt/Equity (TTM)

CLBT0.00x

RSKD0.00x

Debt/Assets (TTM)

CLBT0.0%

RSKD0.0%

Interest Coverage (TTM)

CLBTN/A

RSKDN/A

Net Debt/EBITDA (TTM)

CLBT0.00x

RSKD0.00x

Beta

CLBT1.02

RSKD1.31

52W Performance

CLBT-40.7%

RSKD83.0%

YTD Performance

CLBT-36.9%

RSKD77.3%

% from 52W High

CLBT-43.6%

RSKD-0.5%

% from 52W Low

CLBT17.5%

RSKD130.5%

Asset Turnover (TTM)

CLBT0.55x

RSKD0.96x

FCF Yield (TTM)

CLBT4.6%

RSKD4.0%

Earnings Yield (TTM)

CLBT2.1%

RSKD-1.4%

Dividend Yield (TTM)

CLBTN/A

RSKDN/A

Rule of 40

CLBT42.8

RSKD22.1

EV/GP/RG

CLBT0.28

RSKD0.26

Ticker research

View CLBT research View RSKD research

Metric	CLBT Cellebrite DI Ltd	RSKD Riskified Ltd
Market & Valuation
Market Cap	$2.81B	$1.14B
Enterprise Value	$2.67B	$1.04B
Price	$11.26	$8.53
P/E Ratio	48.87x	N/A
P/S Ratio	5.46x	3.10x
EV/Sales	5.19x	2.81x
EV/EBITDA	28.85x	0.00x
P/B Ratio	5.17x	4.96x
P/FCF Ratio	21.85x	24.79x
EV/FCF	20.75x	22.50x
PEG Ratio	2.85x	N/A
Forward P/E (NTM)	18.00x	26.34x
Forward P/S (NTM)	4.59x	2.61x
Revenue & Growth
Revenue (TTM)	$514M	$368M
Revenue Growth (YoY)	17.8%	9.6%
Forward Rev Growth	15.1%	10.9%
Profitability
Gross Margin (TTM)	83.0%	51.3%
Operating Margin (TTM)	10.9%	0.0%
EBITDA Margin (TTM)	15.2%	-3.6%
Net Margin (TTM)	11.3%	-4.2%
FCF Margin (TTM)	25.0%	12.5%
Net Income (TTM)	$58M	$-16M
FCF (TTM)	$129M	$46M
EPS (TTM)	$0.23	-$0.11
ROE (TTM)	11.9%	-570.0%
ROA (TTM)	6.3%	-405.0%
ROIC (TTM)	11.9%	-570.0%
Financial Health
Cash	$141M	$105M
Debt	$0	$0
Net Cash/Debt	$141M	$105M
Current Ratio (TTM)	1.62x	3.62x
Quick Ratio (TTM)	1.54x	3.45x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.02	1.31
52W Performance	-40.7%	83.0%
YTD Performance	-36.9%	77.3%
% from 52W High	-43.6%	-0.5%
% from 52W Low	17.5%	130.5%
Efficiency & Yields
Asset Turnover (TTM)	0.55x	0.96x
FCF Yield (TTM)	4.6%	4.0%
Earnings Yield (TTM)	2.1%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.8	22.1
EV/GP/RG	0.28	0.26
Ticker research	View CLBT research	View RSKD research

Valuation

P/E Ratio

CLBT

48.87x

P/S Ratio

RSKD

3.10x

CLBT

5.46x

EV/FCF

CLBT

20.75x

RSKD

22.50x

Growth & revenue

Revenue Growth TTM

CLBT

17.8%

RSKD

9.6%

Forward Revenue Growth

CLBT

15.1%

RSKD

10.9%

Profitability & performance

Gross Margin

CLBT

83.0%

RSKD

51.3%

ROE

CLBT

11.9%

RSKD

-570.0%

FCF Yield %

CLBT

4.6%

RSKD

4.0%

52-Week Performance

RSKD

83.0%

CLBT

-40.7%

Detailed metrics comparison

CLBT

Cellebrite DI Ltd

RSKD

Riskified Ltd

Market Cap

CLBT$2.81B

RSKD$1.14B

Enterprise Value

CLBT$2.67B

RSKD$1.04B

Price

CLBT$11.26

RSKD$8.53

P/E Ratio

CLBT48.87x

RSKDN/A

P/S Ratio

CLBT5.46x

RSKD3.10x

EV/Sales

CLBT5.19x

RSKD2.81x

EV/EBITDA

CLBT28.85x

RSKD0.00x

P/B Ratio

CLBT5.17x

RSKD4.96x

P/FCF Ratio

CLBT21.85x

RSKD24.79x

EV/FCF

CLBT20.75x

RSKD22.50x

PEG Ratio

CLBT2.85x

RSKDN/A

Forward P/E (NTM)

CLBT18.00x

RSKD26.34x

Forward P/S (NTM)

CLBT4.59x

RSKD2.61x

Revenue (TTM)

CLBT$514M

RSKD$368M

Revenue Growth (YoY)

CLBT17.8%

RSKD9.6%

Forward Rev Growth

CLBT15.1%

RSKD10.9%

Gross Margin (TTM)

CLBT83.0%

RSKD51.3%

Operating Margin (TTM)

CLBT10.9%

RSKD0.0%

EBITDA Margin (TTM)

CLBT15.2%

RSKD-3.6%

Net Margin (TTM)

CLBT11.3%

RSKD-4.2%

FCF Margin (TTM)

CLBT25.0%

RSKD12.5%

Net Income (TTM)

CLBT$58M

RSKD$-16M

FCF (TTM)

CLBT$129M

RSKD$46M

EPS (TTM)

CLBT$0.23

RSKD-$0.11

ROE (TTM)

CLBT11.9%

RSKD-570.0%

ROA (TTM)

CLBT6.3%

RSKD-405.0%

ROIC (TTM)

CLBT11.9%

RSKD-570.0%

Cash

CLBT$141M

RSKD$105M

Debt

CLBT$0

RSKD$0

Net Cash/Debt

CLBT$141M

RSKD$105M

Current Ratio (TTM)

CLBT1.62x

RSKD3.62x

Quick Ratio (TTM)

CLBT1.54x

RSKD3.45x

Debt/Equity (TTM)

CLBT0.00x

RSKD0.00x

Debt/Assets (TTM)

CLBT0.0%

RSKD0.0%

Interest Coverage (TTM)

CLBTN/A

RSKDN/A

Net Debt/EBITDA (TTM)

CLBT0.00x

RSKD0.00x

Beta

CLBT1.02

RSKD1.31

52W Performance

CLBT-40.7%

RSKD83.0%

YTD Performance

CLBT-36.9%

RSKD77.3%

% from 52W High

CLBT-43.6%

RSKD-0.5%

% from 52W Low

CLBT17.5%

RSKD130.5%

Asset Turnover (TTM)

CLBT0.55x

RSKD0.96x

FCF Yield (TTM)

CLBT4.6%

RSKD4.0%

Earnings Yield (TTM)

CLBT2.1%

RSKD-1.4%

Dividend Yield (TTM)

CLBTN/A

RSKDN/A

Rule of 40

CLBT42.8

RSKD22.1

EV/GP/RG

CLBT0.28

RSKD0.26

Ticker research

View CLBT research View RSKD research

Metric	CLBT Cellebrite DI Ltd	RSKD Riskified Ltd
Market & Valuation
Market Cap	$2.81B	$1.14B
Enterprise Value	$2.67B	$1.04B
Price	$11.26	$8.53
P/E Ratio	48.87x	N/A
P/S Ratio	5.46x	3.10x
EV/Sales	5.19x	2.81x
EV/EBITDA	28.85x	0.00x
P/B Ratio	5.17x	4.96x
P/FCF Ratio	21.85x	24.79x
EV/FCF	20.75x	22.50x
PEG Ratio	2.85x	N/A
Forward P/E (NTM)	18.00x	26.34x
Forward P/S (NTM)	4.59x	2.61x
Revenue & Growth
Revenue (TTM)	$514M	$368M
Revenue Growth (YoY)	17.8%	9.6%
Forward Rev Growth	15.1%	10.9%
Profitability
Gross Margin (TTM)	83.0%	51.3%
Operating Margin (TTM)	10.9%	0.0%
EBITDA Margin (TTM)	15.2%	-3.6%
Net Margin (TTM)	11.3%	-4.2%
FCF Margin (TTM)	25.0%	12.5%
Net Income (TTM)	$58M	$-16M
FCF (TTM)	$129M	$46M
EPS (TTM)	$0.23	-$0.11
ROE (TTM)	11.9%	-570.0%
ROA (TTM)	6.3%	-405.0%
ROIC (TTM)	11.9%	-570.0%
Financial Health
Cash	$141M	$105M
Debt	$0	$0
Net Cash/Debt	$141M	$105M
Current Ratio (TTM)	1.62x	3.62x
Quick Ratio (TTM)	1.54x	3.45x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.02	1.31
52W Performance	-40.7%	83.0%
YTD Performance	-36.9%	77.3%
% from 52W High	-43.6%	-0.5%
% from 52W Low	17.5%	130.5%
Efficiency & Yields
Asset Turnover (TTM)	0.55x	0.96x
FCF Yield (TTM)	4.6%	4.0%
Earnings Yield (TTM)	2.1%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.8	22.1
EV/GP/RG	0.28	0.26
Ticker research	View CLBT research	View RSKD research